From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
about
The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivatorInteraction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsIdentification of guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase. Regulation of MR-GEF by M-Ras-GTP interactionIdentification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cellsIdentification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cellsSupervillin associates with androgen receptor and modulates its transcriptional activityStructure and function of steroid receptor AF1 transactivation domains: induction of active conformationsSteroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferationAkt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptorEBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistanceSpecificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signallingIncrease of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cellsClinical and experimental progression of a new model of human prostate cancer and therapeutic approachNeuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinaseTranscriptional programs activated by exposure of human prostate cancer cells to androgenAcquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismPersistent androgen receptor addiction in castration-resistant prostate cancerAdaptive responses of androgen receptor signaling in castration-resistant prostate cancerCellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressorA novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growthFrom androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivatorActivation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathwaysSuppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cellsSustained proliferation in cancer: Mechanisms and novel therapeutic targetsPhosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligasePterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor statusA novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activityIdentification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.The focal adhesion protein vinexin alpha regulates the phosphorylation and activity of estrogen receptor alpha.Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells.Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites.Androgen receptor phosphorylation: biological context and functional consequences.Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitorsVav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.Characterization of SV-40 Tag rats as a model to study prostate cancer.Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7
P2860
Q22010240-B2F2FCC1-F299-422A-BDA8-D63DB0000D20Q22254244-6FED1A15-5BF2-407F-9063-58CA44539D84Q22254750-9E754C54-DFEF-4300-B134-8AF5CD10BFC2Q24291571-D5623F0B-9361-404B-9965-402F2F20963BQ24300367-D1456B25-E6F3-426A-8BE0-5E0D130213A9Q24530343-2080FD36-B25A-4AE7-8625-9E5B56B8AA1CQ24537137-C8C69E7F-0BC7-4A06-BF31-23F9322D5912Q24631073-E600D8A7-A8C1-48D7-9D85-20DDB752ABDCQ24631156-915CED37-B80D-4C91-B13A-C701A6CE6ABEQ24646417-BE7F3FCB-F9C1-4D57-959E-33BCADF9A47CQ24650935-BEBA87E5-96EB-4E79-A671-3448EBAAB05CQ24675586-EA1A065A-0654-4B1F-A6AB-983E095E2491Q24685731-E0CF6646-E70F-4733-ADF4-5A512BBF51B8Q24746249-45592EFE-8B25-4F20-BD94-EF832B3AF4D3Q24802648-DD7E2129-B833-44E7-A237-331E96BF8EE0Q24815477-651AA178-9F26-4783-871A-85A3DEBD5210Q26774456-56ED162E-B452-4E16-82F5-C5613547C95EQ26777163-88FEECB2-9885-4EFD-A253-5C0975B54603Q26795625-1D5CB7A0-04BC-4E11-889A-C86063FEBEA8Q26863333-486CCDEE-0458-4300-8465-D8500BF5E05BQ28116222-30A17DB7-F1F8-45E2-A703-E26E93707A62Q28139675-95BC08E4-36A5-48B8-818A-2ED84AA9CC5EQ28212733-760EABEF-00DC-44AD-B1F4-8CE27D1752BBQ28265036-792071E4-E106-4EE2-941B-254D628907D7Q28396388-AB79B56E-1E1A-48E9-A789-95B3736F27BFQ28511501-20283981-8C7E-4D9E-B732-C700997AAFC7Q28541923-C91CA7D3-F137-46D1-A4D4-22BF859D7ED4Q28574016-F087347F-5D94-4659-8A01-AF675626AC40Q28727939-A2467640-4F5F-447F-A659-B5FFEA3E497CQ30164406-412D6FCE-E23C-4D50-939A-E4D6665EDDB7Q30306146-CF425B4D-99B4-4846-B0B9-96D30B7A8F32Q30309352-9137E8DA-2AFB-45D0-B70D-59DC838DF066Q30394055-3114362C-AC7E-48E0-9334-76FD754480AEQ30816464-93E1A1C1-9A66-45F6-8FE9-6A888FF28A33Q31081891-1030CC17-BA3B-4A6D-81B1-E157DB1E3C81Q33339736-7B4DA667-09E2-48CB-8A44-337B45AF9F17Q33403060-52ADEC7C-B36E-4955-AB6A-31425E4E26CCQ33529070-895431BE-74A6-45FD-88E3-8DD3A2EFF7ECQ33631775-B0FEAC04-8A72-45D0-A1AD-73120EF62560Q33643318-04AFE8CA-8F7D-4EEE-BD56-972097869FAE
P2860
From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@ast
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@en
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@nl
type
label
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@ast
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@en
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@nl
prefLabel
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@ast
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@en
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@nl
P2093
P2860
P3181
P356
P1476
From HER2/Neu signal cascade t ...... inase in prostate cancer cells
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.96.10.5458
P407
P50
P577
1999-05-01T00:00:00Z